AR043133A1 - Metodo de tratamiento con nelfinavir - Google Patents
Metodo de tratamiento con nelfinavirInfo
- Publication number
- AR043133A1 AR043133A1 ARP040100399A ARP040100399A AR043133A1 AR 043133 A1 AR043133 A1 AR 043133A1 AR P040100399 A ARP040100399 A AR P040100399A AR P040100399 A ARP040100399 A AR P040100399A AR 043133 A1 AR043133 A1 AR 043133A1
- Authority
- AR
- Argentina
- Prior art keywords
- nelfinavir
- treatment method
- hiv
- mammal
- treatment
- Prior art date
Links
- QAGYKUNXZHXKMR-UHFFFAOYSA-N CPD000469186 Natural products CC1=C(O)C=CC=C1C(=O)NC(C(O)CN1C(CC2CCCCC2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-UHFFFAOYSA-N 0.000 title abstract 4
- QAGYKUNXZHXKMR-HKWSIXNMSA-N nelfinavir Chemical compound CC1=C(O)C=CC=C1C(=O)N[C@H]([C@H](O)CN1[C@@H](C[C@@H]2CCCC[C@@H]2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-HKWSIXNMSA-N 0.000 title abstract 4
- 229960000884 nelfinavir Drugs 0.000 title abstract 4
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Método para tratar el virus de la inmunodeficiencia humana (HIV) en un mamífero, que comprende administrar a un mamífero que lo necesite una cantidad terapéuticamente eficaz de nelfinavir en una composición farmacéutica, en el que el nelfinavir se administra con alimentos. Una composición terapéutica para el tratamiento del HIV que comprende grasa y nelfinavir en una relación de peso de al menos 25:1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44644403P | 2003-02-10 | 2003-02-10 | |
US52425803P | 2003-11-21 | 2003-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043133A1 true AR043133A1 (es) | 2005-07-20 |
Family
ID=32853430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040100399A AR043133A1 (es) | 2003-02-10 | 2004-02-09 | Metodo de tratamiento con nelfinavir |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1605942A1 (es) |
JP (1) | JP2006517221A (es) |
AR (1) | AR043133A1 (es) |
BR (1) | BRPI0407174A (es) |
CA (1) | CA2515095A1 (es) |
CL (1) | CL2004000202A1 (es) |
MX (1) | MXPA05008425A (es) |
NL (1) | NL1025449C2 (es) |
PA (1) | PA8595301A1 (es) |
PE (1) | PE20040948A1 (es) |
TW (1) | TW200423922A (es) |
UY (1) | UY28183A1 (es) |
WO (1) | WO2004069251A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7157455B2 (en) | 2003-02-10 | 2007-01-02 | Hoffmann-La Roche Inc. | 4-Aminopyrimidine-5-one derivatives |
-
2004
- 2004-01-29 BR BR0407174-3A patent/BRPI0407174A/pt not_active IP Right Cessation
- 2004-01-29 MX MXPA05008425A patent/MXPA05008425A/es unknown
- 2004-01-29 WO PCT/IB2004/000313 patent/WO2004069251A1/en not_active Application Discontinuation
- 2004-01-29 EP EP04706250A patent/EP1605942A1/en not_active Withdrawn
- 2004-01-29 CA CA002515095A patent/CA2515095A1/en not_active Abandoned
- 2004-01-29 JP JP2006502411A patent/JP2006517221A/ja active Pending
- 2004-02-05 CL CL200400202A patent/CL2004000202A1/es unknown
- 2004-02-09 PA PA20048595301A patent/PA8595301A1/es unknown
- 2004-02-09 TW TW093102921A patent/TW200423922A/zh unknown
- 2004-02-09 PE PE2004000146A patent/PE20040948A1/es not_active Application Discontinuation
- 2004-02-09 AR ARP040100399A patent/AR043133A1/es unknown
- 2004-02-10 NL NL1025449A patent/NL1025449C2/nl not_active IP Right Cessation
- 2004-02-10 UY UY28183A patent/UY28183A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA05008425A (es) | 2005-10-19 |
NL1025449A1 (nl) | 2004-08-12 |
CL2004000202A1 (es) | 2005-03-18 |
TW200423922A (en) | 2004-11-16 |
PA8595301A1 (es) | 2005-08-04 |
CA2515095A1 (en) | 2004-08-19 |
NL1025449C2 (nl) | 2005-03-15 |
UY28183A1 (es) | 2004-09-30 |
PE20040948A1 (es) | 2004-12-27 |
JP2006517221A (ja) | 2006-07-20 |
EP1605942A1 (en) | 2005-12-21 |
WO2004069251A1 (en) | 2004-08-19 |
BRPI0407174A (pt) | 2006-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
ES2190472T3 (es) | Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno. | |
EA200300628A1 (ru) | Соединения, специфические к аденозиновому a, aи aрецептору, и их применение | |
AR045783A1 (es) | Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide | |
AR065580A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
CO5590913A2 (es) | Terapia de combinacion antivirica | |
RU2013123646A (ru) | Комбинированная композиция | |
EA200600817A1 (ru) | Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты) | |
AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
AR052830A1 (es) | Regimen de cladribina para tratar esclerosis multiple | |
PE20211199A1 (es) | Uso de reboxetina para el tratamiento de narcolepsia | |
AR065582A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
AR048806A1 (es) | Uso de cariofilenos en la elaboracion de medicamentos y tratamiento de afecciones corporales de inflamacion y dolor inflamatorio | |
PE20031047A1 (es) | Tratamiento de padecimientos post-menopausicos en pacientes con cancer de mama | |
AR043133A1 (es) | Metodo de tratamiento con nelfinavir | |
PT1220676E (pt) | Prevencao do cancro colorrectal | |
CN105362919A (zh) | 一种外治寒湿痹证的中药制剂 | |
RU2013129824A (ru) | Новое лечение инфекции вируса гепатита с | |
AR045070A1 (es) | Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico | |
AR029160A1 (es) | El uso del interferon-alfa pegilado para la preparacion de un medicamento para el tratamiento del carcinoma de celula renal, un kit y el uso del mismo | |
AR047154A1 (es) | Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol | |
DOP2004000815A (es) | Metodo de tratamiento con nelfinavir | |
AR061046A1 (es) | Mirtazapina para el tratamiento del dolor neuropatico | |
AR045178A1 (es) | Uso de un componente retinoide seleccionado entre el grupo formado por agentes retinoides activos, precursores de agentes retinoides activos y mezclas de los mismos, para preparar una composicion farmaceutica | |
AR120453A1 (es) | Combinación de un inhibidor de btk y un inhibidor de mdm2 para el tratamiento del cáncer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |